Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.450
+0.050 (2.08%)
Jan 29, 2026, 3:28 PM EST - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $225.1 million as of January 29, 2026. Its market cap has increased by 143.63% in one year.
Market Cap
225.10M
Enterprise Value
145.55M
1-Year Change
143.63%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $225.10M, an increase of 341.14%. That is a compound annual growth rate of 41.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 220.51M | 63.27% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 207.40M |
| Editas Medicine | 205.98M |
| Milestone Pharmaceuticals | 204.18M |
| SAB Biotherapeutics | 203.76M |
| Galectin Therapeutics | 203.09M |
| Humacyte | 198.79M |
| Camp4 Therapeutics | 198.70M |
| Sagimet Biosciences | 198.06M |